SK Bioscience aims to list shares on KOSPI market by 1H next year

SK Chemicals

27/11/2020 07:27

SEOUL, Nov 27 (Reuters) - SK Bioscience, a South Korean drug
company, said on Friday that it aims to list its shares on the
country's main stock exchange by the first half of next year.
    The firm, in which SK Chemical  285130.KS  holds a 98.04%
stake, said its board has approved its plan on initial public
offering.
    SK Bioscience has earlier agreed to manufacture
AstraZeneca’s experimental COVID-19 vaccine to help the British
company build global supplies of the vaccine that has shown
promise against the new coronavirus.
    

    

 (Reporting by Sangmi Cha and Hyunjoo Jin;
Editing by Shri Navaratnam)
 ((Sangmi.Cha@thomsonreuters.com; +82 2 3704 5646; Reuters
Messaging: sangmi.cha.thomsonreuters.com@reuters.net))